A steep decline in Ozempic maker Novo Nordisk’s share price has sent consumer confidence in Denmark to a three-month low.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.

Aisleyne Horgan-Wallace, a former Big Brother star, had such an adverse reaction to a suspected fake weight-loss jab she ...